Showing results (11-20 of 534) with videos related to
Sort By:
Pageof 54
Science Translational Medicine|November 1, 2019
Multiple roles for HIV broadly neutralizing antibodiesBarton F Haynes, Dennis R Burton, John R MascolaPhilosophical Transactions of the Royal Society of London. Series B, Biological Sciences|September 7, 2011
Progress in the rational design of an AIDS vaccineGary J Nabel, Peter D Kwong, John R MascolaNature Reviews. Immunology|August 24, 2013
Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginningPeter D Kwong, John R Mascola, Gary J NabelCold Spring Harbor Perspectives in Medicine|January 10, 2012
Rational design of vaccines to elicit broadly neutralizing antibodies to HIV-1Peter D Kwong, John R Mascola, Gary J NabelJournal of the International AIDS Society|July 14, 2012
The changing face of HIV vaccine researchPeter D Kwong, John R Mascola, Gary J NabelNature Medicine|June 16, 2009
Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?Leonidas Stamatatos, Lynn Morris, Dennis R Burton, et al.Immunity|August 4, 2021
Accelerated COVID-19 vaccine development: milestones, lessons, and prospectsKarin Bok, Sandra Sitar, Barney S Graham, et al.Current Opinion in HIV and AIDS|April 18, 2009
Neutralizing and other antiviral antibodies in HIV-1 infection and vaccinationDavid C Montefiori, Lynn Morris, Guido Ferrari, et al.Immunological Reviews|January 31, 2017
Use of broadly neutralizing antibodies for HIV-1 preventionAmarendra Pegu, Ann J Hessell, John R Mascola, et al.Cold Spring Harbor Perspectives in Biology|July 1, 2017
Is It Possible to Develop a "Universal" Influenza Virus Vaccine? Immunogenetic Considerations Underlying B-Cell Biology in the Development of a Pan-Subtype Influenza A Vaccine Targeting the Hemagglutinin StemSarah F Andrews, Barney S Graham, John R Mascola, et al.Pageof 54